OrganiGram (TSE:OGI) had its target price lowered by stock analysts at Alliance Global Partners from C$3.75 to C$3.00 in a research report issued to clients and investors on Wednesday, Analyst Price Targets reports. The firm presently has an “underperform” rating on the stock. Alliance Global Partners’ price objective points to a potential upside of 8.30% from the stock’s previous close.
A number of other analysts have also recently commented on OGI. Jefferies Financial Group increased their price target on shares of OrganiGram from C$3.57 to C$3.83 in a research note on Friday, September 3rd. ATB Capital cut their price target on shares of OrganiGram from C$4.25 to C$2.65 in a research note on Wednesday. CIBC reiterated a “neutral” rating on shares of OrganiGram in a research note on Friday, September 24th. Canaccord Genuity cut their price target on shares of OrganiGram from C$3.50 to C$3.00 in a research note on Wednesday. Finally, Raymond James set a C$5.00 target price on shares of OrganiGram and gave the stock an “outperform” rating in a research note on Friday, November 19th. Three research analysts have rated the stock with a sell rating, four have issued a hold rating and one has assigned a buy rating to the company’s stock. According to data from MarketBeat, OrganiGram has an average rating of “Hold” and an average target price of C$3.54.
Shares of OGI stock opened at C$2.77 on Wednesday. The stock has a market cap of C$827.63 million and a P/E ratio of -4.44. The company has a debt-to-equity ratio of 1.23, a current ratio of 13.70 and a quick ratio of 10.99. The company has a fifty day moving average price of C$2.86 and a two-hundred day moving average price of C$3.20. OrganiGram has a one year low of C$1.52 and a one year high of C$8.00.
Organigram Holdings Inc, through its subsidiaries, produces and sells cannabis and cannabis-derived products in Canada. It offers cannabis flowers, extracts, edibles and oils, beverages, and other cannabis products for adult recreational market under the Edison Reserve, Edison Cannabis Co, ANKR Organics, and Trailblazer brands; and medical cannabis products, including strains, cannabis oils, extracts, edibles, beverages, and vaporizers for the medical market.
Recommended Story: What does the Dogs of the Dow mean?
Receive News & Ratings for OrganiGram Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for OrganiGram and related companies with MarketBeat.com's FREE daily email newsletter.